Imperial College London

Professor M Francesca Cordeiro

Faculty of MedicineDepartment of Surgery & Cancer

Chair in Ophthalmology (Clinical)
 
 
 
//

Contact

 

m.cordeiro

 
 
//

Location

 

Norfolk PlaceSt Mary's Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Almonte:2020:10.1177/2040622320905215,
author = {Almonte, MT and Capellan, P and Yap, TE and Cordeiro, MF},
doi = {10.1177/2040622320905215},
journal = {Therapeutic Advances in Chronic Disease},
pages = {1--21},
title = {Retinal correlates of psychiatric disorders},
url = {http://dx.doi.org/10.1177/2040622320905215},
volume = {11},
year = {2020}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AB - Diagnosis and monitoring of psychiatric disorders rely heavily on subjective self-reports of clinical symptoms, which are complicated by the varying consistency of accounts reported by patients with an impaired mental state. Hence, more objective and quantifiable measures have been sought to provide clinicians with more robust methods to evaluate symptomology and track progression of disease in response to treatments. Owing to the shared origins of the retina and the brain, it has been suggested that changes in the retina may correlate with structural and functional changes in the brain. Vast improvements in retinal imaging, namely optical coherence tomography (OCT) and electrodiagnostic technology, have made it possible to investigate the eye at a microscopic level, allowing for the investigation of potential biomarkers in vivo. This review provides a summary of retinal biomarkers associated with schizophrenia, bipolar disorder and major depression, demonstrating how retinal biomarkers may be used to complement existing methods and provide structural markers of pathophysiological mechanisms that underpin brain dysfunction in psychiatric disorders.
AU - Almonte,MT
AU - Capellan,P
AU - Yap,TE
AU - Cordeiro,MF
DO - 10.1177/2040622320905215
EP - 21
PY - 2020///
SN - 2040-6231
SP - 1
TI - Retinal correlates of psychiatric disorders
T2 - Therapeutic Advances in Chronic Disease
UR - http://dx.doi.org/10.1177/2040622320905215
UR - http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000524530900001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
UR - https://journals.sagepub.com/doi/10.1177/2040622320905215
UR - http://hdl.handle.net/10044/1/81595
VL - 11
ER -